Back

Informing patients about potential adverse drug reactions after percutaneous coronary intervention reduces the occurrence of self-reported adverse drug reactions

26 August 2022 (08:00 - 19:30)
Organised by:
Congress Presentation Part of: Nursing and Allied Professions Investigator Awards Chronic Nursing Care ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Trond Roed Pettersen

Haukeland University Hospital, Bergen (Norway)

3 More presentations in this session

Presentation thumbnail
Clinical impact of improving sarcopenia through cardiac rehabilitation in patients with heart failure
Ms S. Shakuta (Sagamihara, JP)
Abstract Slides Video
Presentation thumbnail
End-of-life and palliative care provision to adults with congenital heart disease: mortality follow-back study using administrative data
Miss L. Van Bulck (Leuven, BE)
Abstract Slides Video
Presentation thumbnail
Sustained effect on diet quality of a self-care intervention to reduce cardiovascular disease risk among informal rural caregivers of people with chronic illnesses: does health literacy matter?
Doctor J. Kang (Lexington, US)
Abstract Slides Video

Access the full session

Session thumbnail
Nursing and Allied Professions Investigator Awards

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022
You may be interested in
thumbnail
Congress Presentation
Abbreviated versus standard dual antiplatelet therapy time after PCI in high bleeding risk patients with acute coronary syndrome - a report from the SWEDEHEART registry
thumbnail
Congress Presentation
Bioresorbable scaffolds revisited
thumbnail
Congress Presentation
Statin non-adherence findings from the My Experience of Taking Statin Medicines Questionnaire (mySTATINmed)

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources